Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets
about
Broad targeting of angiogenesis for cancer prevention and therapyQuantitative characterization of cellular membrane-receptor heterogeneity through statistical and computational modelingWater exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.Characterizing venous vasculatures of hepatocellular carcinoma using a multi-breath-hold two-dimensional susceptibility weighted imaging.Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma.Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling.The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.Hyperplasia of pericytes is one of the main characteristics of microvascular architecture in malignant gliomaRegulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer.Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery.A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.Different types of tumor vessels in breast cancer: morphology and clinical valueA novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling.The challenge of targeting metastasis.Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition.Microengineered tumor models: insights & opportunities from a physical sciences-oncology perspectiveInterstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase.Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma.β-Catenin C-terminal signals suppress p53 and are essential for artery formation.Heterogeneity of tumor vasculature and antiangiogenic intervention: insights from MR angiography and DCE-MRI.Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine.A bioimage informatics based reconstruction of breast tumor microvasculature with computational blood flow predictions.Nanoparticle Interactions with the Immune System: Clinical Implications for Liposome-Based Cancer Chemotherapy.Vascular remodeling in cancer.Heterogeneity of tumor endothelial cells.Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E).Fine-Tuning Tumor Endothelial Cells to Selectively Kill Cancer.Expected Impacts of Connected Multimodal Imaging in Precision Oncology.Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.Use of Ultrasmall Superparamagnetic Iron Oxide Enhanced Susceptibility Weighted Imaging and Mean Vessel Density Imaging to Monitor Antiangiogenic Effects of Sorafenib on Experimental Hepatocellular Carcinoma.Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening.Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles.Tumor Microenvironment-Enabled Nanotherapy.Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.Quantification of antiangiogenic treatment effects on tissue heterogeneity in glioma tumour xenograft model using a combination of DCE-MRI and 3D-ultramicroscopy.Automated image analysis of intra-tumoral and peripheral endocrine organ vascular bed regression using 'Fibrelength' as a novel structural biomarker.Contrast-enhanced susceptibility weighted imaging with ultrasmall superparamagnetic iron oxide improves the detection of tumor vascularity in a hepatocellular carcinoma nude mouse model.Contribution of Tumor Endothelial Cells in Cancer Progression.Studies on the Tumor Vasculature and Coagulant Microenvironment.
P2860
Q27002903-6AF240CB-5021-4945-9315-A610C2ECBB36Q28538791-4D27F827-19AD-433D-9762-3216431F1BF1Q30651989-02589D46-2B28-4273-A437-0CCD3F02C88FQ31120579-1ECE95CB-707A-4BC9-A300-FC802CCC8C79Q33616589-7EE12EDA-45ED-4005-9135-248D82AE4DA4Q33618393-51B8242E-13A5-45AF-9743-071707C96D18Q34365135-3A157ABD-FC82-4033-9830-4A0DCE5A2C3FQ34640644-9DF2858A-2B84-439F-8064-19B58ED623B7Q34921868-1D038B9F-DE2A-4943-910E-538E51E24F34Q35063876-87293EBD-6D16-4162-B341-280D09B2F671Q35547649-76ED30F4-979C-4D60-BB29-3D7A5694004BQ36070111-7B76607F-2980-4372-886C-F28EC15D4286Q36279494-222DDE6C-9E39-4851-ABFD-96A26F6A9C60Q36322825-FE3F59C9-28E6-45DB-B837-43DB18F62B6DQ36828050-DD32BDD0-392E-4E2E-93D2-9EE1B816DE9CQ37022156-CB24B7B3-9163-44D7-B94D-69A1560EA100Q37081606-D3E8517A-E24B-4280-9E6A-BC11D91BBF8CQ37119287-219365C3-0B9B-4D13-AEAC-196AB3F9D998Q37163437-99317C87-DC97-4A7E-8775-1290E1915199Q37510240-4CC71333-05F1-4A2F-A88C-6C66BD38B245Q37562355-C28A1107-CC67-40ED-8CCF-3C8C74B94A6DQ37688862-9297E3D3-8880-4B11-9754-4C673F9B427AQ37739064-EB99DC10-23A0-406D-91D4-0126785FEF60Q38126351-DD3390AF-B97B-4804-B98F-4ECB0EF85009Q38127709-F1A48F7B-D508-4091-80DF-D65C963F70FCQ38682486-7805DF25-DEBB-4614-9476-7C0E5733F96DQ38851509-6D5894B9-E6BD-41C8-B889-D6D26F3ED22EQ39406918-15B48103-CC57-4538-8EE0-F1529B44A5E7Q40428129-3A466D7D-A83C-4BB1-BBB8-E87F2FCB9BF1Q41637262-AB73308E-424B-47D0-857A-107364AD04F1Q43376100-23FD2391-4DCC-4FA8-AE69-2BF0518C2736Q46914962-39CA1853-B992-409C-BD28-9DB6A5F52972Q47093736-F607D0B0-765F-43B5-BDAD-487EF2A0D6F5Q47761233-3DD1CE39-B12C-44B1-9D3B-D20C33F462DDQ48049656-26928EB7-1AA7-435D-BFFD-B6B25CE1179DQ48235199-784FE1BF-2ECC-45CA-A2C0-581EB70AC6F2Q48253400-8DBCD711-E946-4380-9E9C-1160698BA615Q51547237-ECAC5162-B19A-40A7-901E-BE8748D58921Q52563257-EC6C5DD9-D7CE-403B-92B6-04AA2D9E6B79Q52944149-B2FE364C-EC8B-4432-8775-E047D89A981E
P2860
Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Heterogeneity of the tumor vas ...... d vessel type-specific targets
@ast
Heterogeneity of the tumor vas ...... d vessel type-specific targets
@en
type
label
Heterogeneity of the tumor vas ...... d vessel type-specific targets
@ast
Heterogeneity of the tumor vas ...... d vessel type-specific targets
@en
prefLabel
Heterogeneity of the tumor vas ...... d vessel type-specific targets
@ast
Heterogeneity of the tumor vas ...... d vessel type-specific targets
@en
P2860
P1476
Heterogeneity of the tumor vas ...... d vessel type-specific targets
@en
P2093
Harold F Dvorak
Janice A Nagy
P2860
P2888
P304
P356
10.1007/S10585-012-9500-6
P577
2012-06-13T00:00:00Z